Rare Cell Population Analysis in Early-Stage Breast Cancer Patients.

Background: Circulating rare cells participate in breast cancer evolution as systemic components of the disease and thus, are a source of theranostic information. Exploration of cancer-associated rare cells is in its infancy. Objectives: We aimed to investigate and classify abnormalities in the circ...

Descripción completa

Detalles Bibliográficos
Publicado en:Breast Cancer: Basic & Clinical Research pp. 1 - 17
Autores principales: Schreier, Stefan, Budchart, Prapaphan, Borwornpinyo, Suparerk, Adireklarpwong, Lakkana, Chirappapha, Prakasit, Triampo, Wannapong, Lertsithichai, Panuwat
Formato: pictorial research tables/charts Journal Article
Publicado: Sage Publications Inc. 1/10/2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=182194239&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 182194239
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        11782234
        B078
      jtl: Breast Cancer: Basic & Clinical Research
      issn: 11782234
      maglogo: Y
    pubinfo:
      dt: 1/10/2025
      pid: 344
      pub: Sage Publications Inc.
      place: Thousand Oaks, California
    artinfo:
      ui:
        182194239
        182194239
        182194239
        10.1177/11782234241310596
        182194239
      ppf: 1
      ppct: 16
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Rare Cell Population Analysis in Early-Stage Breast Cancer Patients.
      aug:
        au:
          Schreier, Stefan
          Budchart, Prapaphan
          Borwornpinyo, Suparerk
          Adireklarpwong, Lakkana
          Chirappapha, Prakasit
          Triampo, Wannapong
          Lertsithichai, Panuwat
        affil: School of Bioinnovation and Bio-based Product Intelligence, Faculty of Science, Mahidol University, Bangkok, Thailand
      sug:
        subj:
          Cells Analysis
          Breast Neoplasms Diagnosis
          Breast Neoplasms Familial and Genetic
          Early Detection of Cancer Methods
          Cytodiagnosis
          Tumor Markers, Biological
          Human
          Funding Source
          Female
          Adult
          Middle Age
          Aged
          Cell Line, Tumor
          In Situ Hybridization, Fluorescence
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Female
      ab: Background: Circulating rare cells participate in breast cancer evolution as systemic components of the disease and thus, are a source of theranostic information. Exploration of cancer-associated rare cells is in its infancy. Objectives: We aimed to investigate and classify abnormalities in the circulating rare cell population among early-stage breast cancer patients using fluorescence marker identification and cytomorphology. In addition, we sought to determine the dependency of these markers on the presence of tumors. Design: We evaluated the validity of a multi-rare-cell detection platform and demonstrated the utility of a specific rare cell subset as a novel approach to characterize the breast cancer system. Sampling was conducted both before and after tumor resection. Methods: Linearity of the Rarmax platform was established using a spike-in approach. The platform includes red blood cell lysis, leukocyte depletion and high-resolution fluorescence image recording. Rare cell analysis was conducted on 28 samples (before and after surgery) from 14 patients with breast cancer, 20 healthy volunteers and 9 noncancer control volunteers. In-depth identification of rare cells, including circulating tumor cells, endothelial-like cells, erythroblasts, and inflammation-associated cells, was performed using a phenotype and morphology-based classification system. Results: The platform performed linearly over a range of 5 to 950 spiked cells, with an average recovery of 84.6%. Circulating epithelial and endothelial-like cell subsets have been demonstrated to be associated with or independent of cancer with tumor presence. Furthermore, certain cell profile patterns may be associated with treatment-related adverse effects. The sensitivity in detecting tumor-presence and cancer-associated abnormality before surgery was 43% and 85.7%, respectively, and the specificity was 100% and 96.6%, respectively. Conclusion: This study supports the idea of a cancer-associated rare cell abnormality to represent tumor entities as well as systemic cancer. The latter is independent of the apparent clinical cancer.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N